Just like humans, your cat or dog could develop diabetes. The good news is that it’s manageable and if you catch it early, ...

According to Dr Tarryn Dent, Business Unit Lead, Companion Animals, at Zoetis South Africa: “One typically thinks of diabetes ...

Pet diabetes can cause life-threatening complications if not detected early enough. Here's how to spot diabetes in your pet.

As pets are good at hiding discomfort, early health issues may go unnoticed until they are advanced. Read more at ...

Scientists have discovered that human stomach cells can be genetically reprogrammed to act like pancreatic beta cells and ...

Adocia and Tonghua Dongbao have announced positive topline results from a phase 3 clinical trial of BioChaperone Lispro (THDB0206 injection), an ultra-rapid insulin formulation, in adults with type 1 ...

A minimally invasive treatment for severe intervertebral disk disease in small dog breeds is now available at the University ...

This Phase 3 clinical trial on BioChaperone® Lispro (THDB0206 injection) conducted in China in people with Type 1 Diabetes, successfully demonstrated, in comparison with standard of care Humalog®: Non ...

LYON, France, October 15, 2025--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and ...

Support from readers like you keeps The Journal open. You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to ...

Zoetis' relfovetmab product is a long-acting anti-nerve growth factor monoclonal therapy for cats. “The benefits of Portela are significantly improved scores as assessed by cat owners using ...